Jennifer G Andrews1, Shree Pandya2, Christina Trout3, Treeva Jaff4, Dennis Matthews5, Christopher Cunniff6, F John Meaney1. 1. Department of Pediatrics, The University of Arizona, Tucson, AZ, USA. 2. Department of Neurology and School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA. 3. The University of Iowa Wellstone Muscular Dystrophy Cooperative Research Center, Iowa City, IA, USA. 4. Birth Defects Registry and Surveillance Section, New York State Department of Health, Albany, NY, USA. 5. School of Medicine, University of Colorado, Denver, CO, USA. 6. Department of Pediatrics, Joan and Sanford I. Weill Medical College, Cornell University, New York, NY, USA.
Abstract
INTRODUCTION: Information on use of palliative care services among individuals with Duchenne and Becker muscular dystrophy is scant despite the clearly documented need. METHODS: We examined associations between uptake of palliative care services by 233 males with Duchenne and Becker muscular dystrophy aged 12 and older for both caregiver and affected male characteristics using the Muscular Dystrophy Surveillance Tracking and Research Network baseline interview. RESULTS: Ninety-one percent of caregivers (213/233) used at least one palliative care service. Case management had the highest frequency of use (59%). Use of palliative care was more frequently associated with the characteristics of affected males, as were some individual palliative care services. Utilization of six individual services differed among Muscular Dystrophy Surveillance Tracking and Research Network sites. While research suggests that pain is a frequent problem in Duchenne and Becker muscular dystrophy, only 12.5% reported use of pain management services. DISCUSSION: Although palliative care use among families of males with Duchenne and Becker muscular dystrophy is high overall, there is much variability in use of individual services. Use of palliative care is driven by disease experience in the affected male. Many of the care recommendations for these individuals highlight the importance for early involvement of palliative care professionals.
INTRODUCTION: Information on use of palliative care services among individuals with Duchenne and Becker muscular dystrophy is scant despite the clearly documented need. METHODS: We examined associations between uptake of palliative care services by 233 males with Duchenne and Becker muscular dystrophy aged 12 and older for both caregiver and affected male characteristics using the Muscular Dystrophy Surveillance Tracking and Research Network baseline interview. RESULTS: Ninety-one percent of caregivers (213/233) used at least one palliative care service. Case management had the highest frequency of use (59%). Use of palliative care was more frequently associated with the characteristics of affected males, as were some individual palliative care services. Utilization of six individual services differed among Muscular Dystrophy Surveillance Tracking and Research Network sites. While research suggests that pain is a frequent problem in Duchenne and Becker muscular dystrophy, only 12.5% reported use of pain management services. DISCUSSION: Although palliative care use among families of males with Duchenne and Becker muscular dystrophy is high overall, there is much variability in use of individual services. Use of palliative care is driven by disease experience in the affected male. Many of the care recommendations for these individuals highlight the importance for early involvement of palliative care professionals.
Entities:
Keywords:
Becker muscular dystrophy; Duchenne muscular dystrophy; caregiver survey; palliative care use; service utilization
Authors: Michelle Eagle; Simon V Baudouin; Colin Chandler; David R Giddings; Robert Bullock; Kate Bushby Journal: Neuromuscul Disord Date: 2002-12 Impact factor: 4.296
Authors: Jonathan D Finder; David Birnkrant; John Carl; Harold J Farber; David Gozal; Susan T Iannaccone; Thomas Kovesi; Richard M Kravitz; Howard Panitch; Craig Schramm; Mary Schroth; Girish Sharma; Lisa Sievers; Jean M Silvestri; Laura Sterni Journal: Am J Respir Crit Care Med Date: 2004-08-15 Impact factor: 21.405
Authors: Sarah K Nabukera; Paul A Romitti; Kimberly A Campbell; F John Meaney; Kristin M Caspers; Katherine D Mathews; Stacey M Hockett Sherlock; Soman Puzhankara; Christopher Cunniff; Charlotte M Druschel; Shree Pandya; Dennis J Matthews; Emma Ciafaloni Journal: J Child Neurol Date: 2011-12-07 Impact factor: 1.987
Authors: Rebeca Arias; Jennifer Andrews; Shree Pandya; Kathleen Pettit; Christina Trout; Susan Apkon; Jane Karwoski; Christopher Cunniff; Dennis Matthews; Timothy Miller; Melinda F Davis; F John Meaney Journal: Muscle Nerve Date: 2011-07 Impact factor: 3.217
Authors: Lisa A Miller; Paul A Romitti; Christopher Cunniff; Charlotte Druschel; Katherine D Mathews; F John Meaney; Dennis Matthews; Jiji Kantamneni; Zhen-Fang Feng; Nancy Zemblidge; Timothy M Miller; Jennifer Andrews; Deborah Fox; Emma Ciafaloni; Shree Pandya; April Montgomery; Aileen Kenneson Journal: Birth Defects Res A Clin Mol Teratol Date: 2006-11
Authors: Ching H Wang; Carsten G Bonnemann; Anne Rutkowski; Thomas Sejersen; Jonathan Bellini; Vanessa Battista; Julaine M Florence; Ulrike Schara; Pamela M Schuler; Karim Wahbi; Annie Aloysius; Robert O Bash; Christophe Béroud; Enrico Bertini; Kate Bushby; Ronald D Cohn; Anne M Connolly; Nicolas Deconinck; Isabelle Desguerre; Michelle Eagle; Brigitte Estournet-Mathiaud; Ana Ferreiro; Albert Fujak; Nathalie Goemans; Susan T Iannaccone; Patricia Jouinot; Marion Main; Paola Melacini; Wolfgang Mueller-Felber; Francesco Muntoni; Leslie L Nelson; Jes Rahbek; Susana Quijano-Roy; Caroline Sewry; Kari Storhaug; Anita Simonds; Brian Tseng; Jiri Vajsar; Andrea Vianello; Reinhard Zeller Journal: J Child Neurol Date: 2010-11-15 Impact factor: 1.987